Latest Videos
Yoav Golan, MD, discusses the paradigm shift occurring in treatment for ABSSSI and how to motivate clinicians to buy into new programs and protocols.
Peter L. Salgo, MD; Bruce M. Jones, PharmD, BCPS; and Yoav Golan, MD, hypothesize on theoretical downsides of resistance development for gram-negative infections and reflect on the importance of implementing outpatient parenteral antibiotic therapy.
The program calls for new research and development incentives, veterinary stewardship, and enhanced surveillance.
The CDC and FDA are investigating a multistate outbreak of Salmonella Enteritidis linked with Gravel Ridge Farms shell eggs.
Big advances in treatment can